Catalyst Wire Dossier Catalyst Wire Dossier

ezogabine/retigabine MR formulations

ezogabine (retigabine) · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ezogabine/retigabine MR formulations, covering 2018-06-19 to 2018-06-19. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation. [Phase 1]

See pricing